BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33463130)

  • 1. Epigallocatechin-3-gallate Enhances the Efficacy of MicroRNA-34a Mimic and MicroRNA-93 Inhibitor Co-transfection in Prostate Cancer Cell Line.
    Mokhtari H; Yaghmaei B; Sirati-Sabet M; Jafari N; Mardomi A; Abediankenari S; Mahrooz A
    Iran J Allergy Asthma Immunol; 2020 Dec; 19(6):612-623. PubMed ID: 33463130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of encomir-93 mimic transfection on the expression of miR-93 and PSA and androgen receptor in prostate cancer LNcap cell line.
    Mokhtari H; Ebrahimi A; Nejati M; Barartabar Z; Damchi M; Khonakdar-Tarsi A; Zahedi M
    Horm Mol Biol Clin Investig; 2023 Sep; 44(3):237-241. PubMed ID: 36995990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of androgen receptor and PSA genes in LNCaP (prostate cancer) cell line due to high concentrations of EGCG, an active ingredient in green tea.
    Bakhshandeh N; Mohammadi M; Mohammadi P; Nazari E; Damchi M; Khodabandelu S; Mokhtari H
    Horm Mol Biol Clin Investig; 2023 Jun; 44(2):181-186. PubMed ID: 36578191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of androgen receptor signaling and prostate specific antigen expression by (-)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells.
    Chuu CP; Chen RY; Kokontis JM; Hiipakka RA; Liao S
    Cancer Lett; 2009 Mar; 275(1):86-92. PubMed ID: 18977589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of microRNAs 371 and 34a in androgen receptor control influencing prostate cancer behavior.
    Leite KR; Morais DR; Florez MG; Reis ST; Iscaife A; Viana N; Moura CM; Silva IA; Katz BS; Pontes J; Nesrallah A; Srougi M
    Urol Oncol; 2015 Jun; 33(6):267.e15-22. PubMed ID: 25920548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of miR-30b-3p and miR-30d-5p as direct regulators of androgen receptor signaling in prostate cancer by complementary functional microRNA library screening.
    Kumar B; Khaleghzadegan S; Mears B; Hatano K; Kudrolli TA; Chowdhury WH; Yeater DB; Ewing CM; Luo J; Isaacs WB; Marchionni L; Lupold SE
    Oncotarget; 2016 Nov; 7(45):72593-72607. PubMed ID: 27683042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent effect of liver X receptor agonists on prostate-specific antigen expression is dependent on androgen receptor in prostate carcinoma cells.
    Tsui KH; Chung LC; Feng TH; Lee TY; Chang PL; Chen WT; Juang HH
    Prostate; 2015 May; 75(6):603-15. PubMed ID: 25560459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells.
    Östling P; Leivonen SK; Aakula A; Kohonen P; Mäkelä R; Hagman Z; Edsjö A; Kangaspeska S; Edgren H; Nicorici D; Bjartell A; Ceder Y; Perälä M; Kallioniemi O
    Cancer Res; 2011 Mar; 71(5):1956-67. PubMed ID: 21343391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
    Liu X; Luo X; Wu Y; Xia D; Chen W; Fang Z; Deng J; Hao Y; Yang X; Zhang T; Zhou L; Wu Y; Wang Q; Xu J; Hu X; Li L
    Cell Physiol Biochem; 2018; 50(1):261-276. PubMed ID: 30282072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-185 downregulates androgen receptor expression in the LNCaP prostate carcinoma cell line.
    Liu C; Chen Z; Hu X; Wang L; Li C; Xue J; Zhang P; Chen W; Jiang A
    Mol Med Rep; 2015 Jun; 11(6):4625-32. PubMed ID: 25673182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGCG enhances cancer cells sensitivity under
    Kang Q; Zhang X; Cao N; Chen C; Yi J; Hao L; Ji Y; Liu X; Lu J
    Food Chem Toxicol; 2019 Nov; 133():110807. PubMed ID: 31494133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
    Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
    Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of compound Chinese traditional medicine PC-SPES II in inhibiting proliferation of human prostate cancer cell LNCaP and on expressions of AR and PSA].
    Zhang BY; Li YF; Lai Y; Li YS; Chen ZJ
    Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(5):950-6. PubMed ID: 26087562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
    Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC
    Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP).
    Koochekpour S; Lee TJ; Wang R; Culig Z; Delorme N; Caffey S; Marrero L; Aguirre J
    Prostate; 2007 Feb; 67(2):178-89. PubMed ID: 17044040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capillarisin blocks prostate-specific antigen expression on activation of androgen receptor in prostate carcinoma cells.
    Tsui KH; Chang YL; Feng TH; Hou CP; Lin YH; Yang PS; Lee BW; Juang HH
    Prostate; 2018 Mar; 78(4):242-249. PubMed ID: 29164633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docetaxel down-regulates the expression of androgen receptor and prostate-specific antigen but not prostate-specific membrane antigen in prostate cancer cell lines: implications for PSA surrogacy.
    Kuroda K; Liu H; Kim S; Guo M; Navarro V; Bander NH
    Prostate; 2009 Oct; 69(14):1579-85. PubMed ID: 19575420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gum mastic inhibits the expression and function of the androgen receptor in prostate cancer cells.
    He ML; Yuan HQ; Jiang AL; Gong AY; Chen WW; Zhang PJ; Young CY; Zhang JY
    Cancer; 2006 Jun; 106(12):2547-55. PubMed ID: 16691616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines.
    Sun T; Wang Q; Balk S; Brown M; Lee GS; Kantoff P
    Cancer Res; 2009 Apr; 69(8):3356-63. PubMed ID: 19351832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel regulation of PSMA and PSA expression by Q640X AR in 22Rv1 and LNCaP prostate cancer cells.
    Ben Jemaa A; Sallami S; Céraline J; Oueslati R
    Cell Biol Int; 2013 May; 37(5):464-70. PubMed ID: 23418075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.